haloperidol has been researched along with Ataxia in 17 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We examined the effects of six compounds (memantine, dextromethorphan, haloperidol, lamotrigine, oxcarbazepine, and topiramate) on sensitivity to acute intoxicating effects of ethanol (ataxia, hypothermia, sedation/hypnosis) in C57BL/6J mice." | 3.75 | Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress. ( Chen, YC; Holmes, A, 2009) |
| "Rats treated with haloperidol at a dose of 1 mg/kg exhibited impaired motor coordination and a decrease in exploratory activity." | 1.34 | Reversal of haloperidol-induced extrapyramidal symptoms by buspirone: a time-related study. ( Haleem, DJ; Haleem, MA; Samad, N, 2007) |
| "NMDA-induced convulsions were effectively prevented by both mono- and dications, while only dications were effective against kainate convulsions." | 1.32 | The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals. ( Gmiro, VE; Gorbunova, LV; Lukomskaya, NY; Rukoyatkina, NI, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wise, LD | 1 |
| Butler, DE | 1 |
| DeWald, HA | 1 |
| Lustgarten, D | 1 |
| Coughenour, LL | 1 |
| Downs, DA | 2 |
| Heffner, TG | 2 |
| Pugsley, TA | 1 |
| Bridges, AJ | 1 |
| Moos, WH | 1 |
| Szotek, DL | 1 |
| Trivedi, BK | 1 |
| Bristol, JA | 1 |
| Bruns, RF | 1 |
| Chen, YC | 1 |
| Holmes, A | 1 |
| Marchione, P | 1 |
| Vento, C | 1 |
| Marianetti, M | 1 |
| Romeo, T | 1 |
| Amabile, GA | 1 |
| Giacomini, P | 1 |
| Rukoyatkina, NI | 1 |
| Gorbunova, LV | 3 |
| Gmiro, VE | 3 |
| Lukomskaya, NY | 1 |
| Haleem, DJ | 1 |
| Samad, N | 1 |
| Haleem, MA | 1 |
| Castellani, S | 1 |
| Adams, PM | 1 |
| Ikeda, H | 1 |
| McAllister, KH | 1 |
| Rey, B | 1 |
| Rukoiatkina, NI | 2 |
| Lukomskaia, NIa | 2 |
| Satar, S | 1 |
| Yilmaz, HL | 1 |
| Gokel, Y | 1 |
| Toprak, N | 1 |
| Maeda, H | 1 |
| Vasar, EE | 1 |
| Allikmets, LKh | 1 |
| Soosaar, AKh | 1 |
| Critchley, EM | 1 |
| Clark, DB | 1 |
| Wikler, A | 1 |
| Brittain, RT | 1 |
| Loew, DM | 1 |
17 other studies available for haloperidol and Ataxia
| Article | Year |
|---|---|
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Ataxia; Avoidance Learning; Brain; Cebus; Chemical Pheno | 1986 |
N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity.
Topics: Adenosine; Animals; Antipsychotic Agents; Ataxia; Avoidance Learning; Dose-Response Relationship, Dr | 1987 |
Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress.
Topics: Alcoholic Intoxication; Animals; Ataxia; Carbamazepine; Central Nervous System Depressants; Consciou | 2009 |
Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Antihypertensive Agents; Ataxia; Cerebellum; Dose-Res | 2009 |
The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals.
Topics: Animals; Ataxia; Behavior, Animal; Catalepsy; Diamines; Disease Models, Animal; Dizocilpine Maleate; | 2003 |
Reversal of haloperidol-induced extrapyramidal symptoms by buspirone: a time-related study.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Ataxia; Buspirone; Catalepsy; Dyskinesia, Drug-I | 2007 |
Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat.
Topics: Analysis of Variance; Animals; Apomorphine; Ataxia; Behavior, Animal; Corpus Striatum; Dose-Response | 1981 |
[Pharmacological studies on the functional development of the central nervous system in first generation rats born to phenytoin-treated mothers (author's transl)].
Topics: Animals; Animals, Newborn; Ataxia; Birth Rate; Brain; Catalepsy; Diazepam; Eye; Feeding Behavior; Fe | 1982 |
Clozapine reversal of the deficits in coordinated movement induced by D2 receptor blockade does not depend upon antagonism of alpha2 adrenoceptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Ataxia; Clozapine; D | 1999 |
[Glutamate receptor antagonists attenuate experimental catalepsy in rats].
Topics: Adamantane; Animals; Antipsychotic Agents; Ataxia; Catalepsy; Diamines; Dizocilpine Maleate; Dose-Re | 2000 |
[Ability of novel non-competitive glutamate receptor blocking agents to weaken motor disorders in animals].
Topics: Animals; Anticonvulsants; Ataxia; Benzene Derivatives; Catalepsy; Cations; Cyclohexanes; Excitatory | 2001 |
A case of child abuse: haloperidol poisoning of a child caused by his mother.
Topics: Antipsychotic Agents; Ataxia; Biperiden; Child Abuse; Child, Preschool; Haloperidol; Humans; Male; P | 2001 |
Effects of psychotropic drugs upon the hypothalamic rage response in cats.
Topics: Anger; Animals; Ataxia; Cats; Chlorpromazine; Diazepam; Haloperidol; Hypothalamus; Hypothalamus, Mid | 1976 |
[Antagonism of caerulein, a CCK-8 receptor agonist, to the behavioral effects of ketamine in mice and rats].
Topics: Amnesia; Animals; Ataxia; Behavior, Animal; Ceruletide; Haloperidol; Ketamine; Male; Mice; Motor Act | 1988 |
An adult form of acanthocytosis.
Topics: Abetalipoproteinemia; Adult; Ataxia; Diazepam; Female; Haloperidol; Humans; Huntington Disease; Hydr | 1967 |
The intracerebral effects of noradrenaline and its modification by drugs in the mouse.
Topics: Amitriptyline; Animals; Antidepressive Agents; Ataxia; Atropine; Body Temperature; Brain; Central Ne | 1966 |
The prediction of sedative potency of neuroleptics.
Topics: Animals; Ataxia; Avoidance Learning; Catalepsy; Chlorpromazine; Haloperidol; Humans; Hypnotics and S | 1970 |